A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee

Trial Identifier:	SAD18258
Sponsor:	Sanofi
Start Date:	November 2024
Primary Completion Date:	December 2025
Study Completion Date:	December 2025
Condition:	OA

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GERMANY	BERLIN, GERMANY, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.